Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:award |
gptkb:Fellow_of_the_Australian_Academy_of_Health_and_Medical_Sciences
gptkb:Fellow_of_the_Australian_Academy_of_Science |
| gptkbp:birthPlace |
gptkb:Australia
|
| gptkbp:education |
gptkb:University_of_Melbourne
|
| gptkbp:employer |
gptkb:Griffith_University
|
| gptkbp:field |
medicinal chemistry
glycobiology |
| https://www.w3.org/2000/01/rdf-schema#label |
Mark von Itzstein
|
| gptkbp:knownFor |
development of the anti-influenza drug Relenza
|
| gptkbp:nationality |
gptkb:Australian
|
| gptkbp:occupation |
gptkb:researchers
chemist |
| gptkbp:position |
Director of the Institute for Glycomics
|
| gptkbp:bfsParent |
gptkb:zanamivir
|
| gptkbp:bfsLayer |
6
|